Serum Institute disclosed Covishield side effects since 2021

mypunepulse.com — May 9, 2024 at 08:00 AM UTC

The Serum Institute of India disclosed rare side effects of Covishield since 2021, following AstraZeneca's global vaccine withdrawal due to updated options. SII, using AstraZeneca's formula, ceased Covishield production in December 2021 due to decreased demand amid new variants. The vaccine's packaging insert includes information on thrombosis with thrombocytopenia syndrome (TTS), a rare but serious side effect involving blood clots with low platelet counts.

With a significance score of 2.5, this news ranks in the top 39% of today's 29123 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 9000 minimalists.